Shank3 as a potential biomarker of antidepressant response to ketamine and its neural correlates in bipolar depression
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
Background Shank3, a post-synaptic density protein involved in N-methyl-D-aspartate (NMDA) receptor tethering and dendritic spine rearrangement, is implicated in the pathophysiology of bipolar disorder. We hypothesized that elevated baseline plasma Shank3 levels might predict antidepressant response to the NMDA antagonist ketamine. Methods Twenty-nine subjects with bipolar depression received a double-blind, randomized, subanesthetic dose (0.5 mg/kg) ketamine infusion. Of the patients for whom Shank3 levels were collected, 15 completed baseline 3-Tesla MRI and 17 completed post-ketamine [18F]-FDG PET. Results Higher baseline Shank3 levels predicted antidepressant response at Days 1 (r=−.39, p=.047), 2 (r=−.45, p=.02), and 3 (r=−.42, p=.03) and were associated with larger average (r=.58, p=.02) and right amygdala volume (r=.65, p=.009). Greater baseline Shank3 also predicted increased glucose metabolism in the hippocampus (r=.51, p=.04) and amygdala (r=.58, p=0.02). Limitations Limitations include the small sample size, inability to assess the source of peripheral Shank3, and the lack of a placebo group for baseline Shank3 levels and comparative structural/functional neuroimaging. Conclusions Shank3 is a potential biomarker of antidepressant response to ketamine that correlates with baseline amygdala volume and increased glucose metabolism in the amygdala and hippocampus.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Shank3 mutant mice display autistic-like behaviours and striatal dysfunction
Peça, J., Feliciano, C., Ting, J. T., Wang, W., Wells, M. F., Venkatraman, T. N., Lascola, C. D., Fu, Z., & Feng, G. (2011) · Nature · doi:10.1038/nature09965 · Cited by 1,570 · cited 2×
“In mice deficient in ubiquitin transfer (Uba6-Use1), altered spine density was observed in the amygdala and hippocampus in conjunction with increased amygdala levels of Shank3 (Lee et al., 2013; Peca et al., 2011); these mice also displayed hyperactive and anxious behaviors.”
BackgroundUntreated Depression and Hippocampal Volume Loss
Sheline, Y. I., Gado, M. H., & Kraemer, H. C. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.8.1516 · Cited by 1,180 · cited 5×
“, 2013) whereas smaller hippocampal volumes have been reported in untreated depression (Sheline et al., 2003).”
BackgroundMethodInfluentialDiazgranados, N., Ibrahim, L., Brutsche, N. E., Newberg, A., Kronstein, P., Khalife, S., Kammerer, W. A., Quezado, Z., Luckenbaugh, D. A., Salvadore, G., et al. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.90 · Cited by 963 · cited 6×
“The design of the original phase Ib studies from which these data were drawn (Diazgranados et al., 2010; Zarate et al., 2012) was identical.”
BackgroundMethodSelf-citationZarate, C. A., Brutsche, N. E., Ibrahim, L., Franco-Chaves, J., Diazgranados, N., Cravchik, A., Selter, J., Marquardt, C. A., Liberty, V., & Luckenbaugh, D. A. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.12.010 · Cited by 811 · cited 5×
“The design of the original phase Ib studies from which these data were drawn (Diazgranados et al., 2010; Zarate et al., 2012) was identical.”
BackgroundMethodSelf-citationDavies, M. N., Volta, M., Pidsley, R., Lunnon, K., Dixit, A., Lovestone, S., Coarfa, C., Harris, R. A., Milosavljevic, A., Troakes, C., et al. (2012) · Genome Biology · doi:10.1186/gb-2012-13-6-r43 · Cited by 630 · cited 1×
“Because blood and brain expression may correlate in vivo (Davies et al., 2012), these cells may serve as sources of Shank3 in peripheral blood and correlate with central neurobiological processes.”
BackgroundDetermination of the rate of the glutamate/glutamine cycle in the human brain by in vivo 13 C NMR
Shen, J., Petersen, K. F., Behar, K. L., Brown, P., Nixon, T. W., Mason, G. F., Petroff, O. A. C., Shulman, G. I., Shulman, R. G., & Rothman, D. L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.14.8235 · Cited by 462 · cited 2×
“Finally, we assessed glucose metabolism via [(18)F]-fluorodeoxyglucose positron emission tomography ([(18)F]-FDGPET) because most glucose in the CNS is ultimately cycled into glutamate (Sheline et al., 2003; Shen et al., 1999).”
MethodDeakin, J. F. W., Lees, J., McKie, S., Hallak, J. E. C., Williams, S. R., & Dursun, S. M. (2008) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2007.37 · Cited by 311 · cited 3×
“, 2011), and hippocampal function, specifically, has been associated with ketamine treatment (Deakin et al., 2008; Nugent et al., 2014).”
BackgroundShank Expression Is Sufficient to Induce Functional Dendritic Spine Synapses in Aspiny Neurons
Roussignol, G., Ango, F., Romorini, S., Tu, J. C., Sala, C., Worley, P. F., Bockaert, J., & Fagni, L. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4354-04.2005 · Cited by 293
Duman, R. S. (2014) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2014.16.1/rduman · Cited by 249 · cited 2×
“NMDA receptor antagonism rapidly increases spine density (Duman, 2014); Contents lists available at ScienceDirect”
BackgroundInfluentialThe emerging role of SHANK genes in neuropsychiatric disorders
Guilmatre, A., Huguet, G., Delorme, R., & Bourgeron, T. (2014) · Developmental Neurobiology · doi:10.1002/dneu.22128 · Cited by 237
Remodeling of axo-spinous synapses in the pathophysiology and treatment of depression
Licznerski, P., & Duman, R. S. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2012.09.057 · Cited by 157
Bringas, M. E., Carvajal-Flores, F. N., López-Ramírez, T. A., Atzori, M., & Flores, G. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.03.030 · Cited by 114 · cited 2×
“dendritic spine rearrangement in learning and memory (Bringas et al., 2013; Pillai et al., 2012; Serafini, 2012)—and are likely related to the subcellular localization and expression of Shank3 leading to these downstream effects, including alterations in dendritic spine density.”
BackgroundDeveloping biomarkers in mood disorders research through the use of rapid-acting antidepressants
Niciu, M. J., Mathews, D. C., Nugent, A. C., Ionescu, D. F., Furey, M. L., Richards, E. M., Machado-Vieira, R., & Zarate, C. A. (2014) · Depression and Anxiety · doi:10.1002/da.22224 · Cited by 45 · cited 1×
“Towards this end, studies from our and other laboratories have sought biomarkers of rapid antidepressant response (Niciu et al., 2014).”
BackgroundSelf-citation
Cited by
Iadarola, N. D., Niciu, M. J., Richards, E. M., Vande Voort, J. L., Ballard, E. D., Lundin, N. B., Nugent, A. C., Machado-Vieira, R., & Zarate, C. A. (2015) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622315579059 · Cited by 201
Self-citationCui, X., Niu, W., Kong, L., He, M., Jiang, K., Chen, S., Zhong, A., Li, W., Lu, J., & Zhang, L. (2016) · Biomarkers in Medicine · doi:10.2217/bmm-2016-0130 · Cited by 150
Animal models of bipolar mania: The past, present and future
Logan, R. W., & McClung, C. A. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2015.08.041 · Cited by 136
Blood biomarkers and treatment response in major depression
Mora, C., Zonca, V., Riva, M. A., & Cattaneo, A. (2018) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2018.1470927 · Cited by 107
“In addition, Ortiz identified a postsynaptic density protein involved in NMDA receptor functioning, SHANK3, as a potential biomarker, as higher levels of this protein predict an antidepressant response at different time points after ketamine infusion [123].”
BackgroundVerdonk, F., Petit, A.-C., Abdel-Ahad, P., Vinckier, F., Jouvion, G., de Maricourt, P., De Medeiros, G. F., Danckaert, A., Van Steenwinckel, J., Blatzer, M., et al. (2019) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2019.06.033 · Cited by 99
Metadata
- Authors
- Ortiz, R., Niciu, M. J., Lukkahati, N., Saligan, L. N., Nugent, A. C., Luckenbaugh, D. A., Machado-Vieira, R., & Zarate, C. A.
- Venue
- Journal of Affective Disorders
- Publisher
- Elsevier BV
- Published
- 2015-02
- Volume
- 172
- Pages
- 307-311
- ISSN
- 0165-0327 (ISSN-L)
- OpenAlex
- W2073250374
- Cited by
- 32
- References
- 13
- FWCI
- 2.60
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.